Company overview

Incorporated in 1980, Amgen is the world's largest biotechnology company engaged in the discovery, development, manufacture and marketing of human therapeutics based on advances in cellular and molecular biology. Amgen’s research and development programmes focus primarily on hematology, oncology, inflammation, neurology and metabolic disorders. In July 2002, the group acquired Immunex Corporation, a biopharmaceutical company dedicated to developing immune system science to protect human health.

Address:
Phone:
Website:
Registrars:
N/A

Company listing

EPIC AMGN
Sector N/A
ISIN US0311621009
Market Sector N/A
Market Segment UNKN
Main Indices S&P 500, Dow Jones I.A., Nasdaq 100, Nasdaq Composite, S&P 100
Country of register United States
Currency United States Dollar
Market Cap 147518.64924316
NMS 0
Shares in issue (m) 537
Date Listed 02-12-2

Key personnel

Events